Marijuana: Clinical, Research, Policy

Challenges of marijuana research.

The use of any drug ideally represents a decision based on objective, scientifically based cost–benefit analyses that factor in both the short and long-term effects of that exposure. Pharmacological, toxicological, pharmacokinetic and phar-macodynamic investigations that are deemed to be essential for the rational use of any therapeutic agent are therefore part of the usual drug approval proces...

Policy strategies to reduce youth recreational marijuana use.

Legalization of marijuana for recreational use among adults could significantly increase access to the drug among youth and is a growing concern for pediatric health in the United States. In a January 2015 policy statement, the American Academy of Pediatrics (AAP) reaffirmed its opposition to legalization of recreational marijuana because of potential harms to youth. Alongside efforts to promot...

The impact of marijuana policies on youth: clinical, research, and legal update.

This technical report updates the 2004 American Academy of Pediatrics technical report on the legalization of marijuana. Current epidemiology of marijuana use is presented, as are definitions and biology of marijuana compounds, side effects of marijuana use, and effects of use on adolescent brain development. Issues concerning medical marijuana specifically are also addressed. Concerning legali...

New CMAJ policy on sharing data from clinical research.

Ethics in Clinical Research

There is no English abstract.